I'm curious about the high failure rate of drugs during development. Specifically, why do approximately 90% of drugs fail to make it through the process and get approved for use by patients?
Poor drug-like properties are the third reason, contributing to 10% to 15% of the failures. This refers to drugs that may not have the ideal characteristics for effective treatment or may not be suitable for human use.
Was this helpful?
226
26
LuciaThu Dec 12 2024
Clinical trial data from the years 2010 to 2017 has been analyzed to understand the reasons behind the high failure rate of drug development.
Was this helpful?
231
20
MicheleThu Dec 12 2024
The fourth reason for clinical failure is the lack of commercial needs and poor strategic planning, accounting for 10% of the failures. This highlights the importance of understanding market demands and developing a robust strategic plan during drug development.
Was this helpful?
163
36
NicolaThu Dec 12 2024
The analysis reveals four primary factors contributing to the 90% clinical failure rate. The first reason is the lack of clinical efficacy, which accounts for 40% to 50% of the failures.
Was this helpful?
149
35
BonsaiVitalityThu Dec 12 2024
The second reason is unmanageable toxicity, responsible for approximately 30% of the clinical failures. This indicates that many drugs, despite showing promise in initial stages, are found to have severe side effects during clinical trials.